NCBP2 and bladder transitional cell carcinoma: Regarding the expression of NCBP2 and DSS, a significant positive association was observed in LIHC, PAAD, LUAD, and UCEC, and a negative association was observed in BLCA (Fig. S3A), and patients (LIHC, PAAD, UCEC) with higher expression of NCBP2 shown worse DSS compared to those with lower expression of NCBP2 (Figs. S3B–S3G).